Peter Attia· MD
but you're saying the way you go about inhibiting mtor will shift the lever more towards maybe inhibition of senescence versus protein synthesis versus autophagy so right okay we'll come back to that
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but you're saying the way you go about inhibiting mtor will shift the lever more towards maybe inhibition of senescence versus protein synthesis versus autophagy so right okay we'll come back to that
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so it's not just which dose of mtor inhibitor but what downstream readout of mtor is equivalent are you looking at autophagy or are you looking at protein synthesis each one uh so you're saying i mean we're going to come back to this joan when we talk about the difference between the allosteric and the catalytic inhibitors